HEADER TRANSFERASE/HYDROLASE/INHIBITOR 09-MAY-17 5VQV TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN TITLE 2 COMPLEX WITH N-(6-CYANO-3-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- TITLE 3 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE TITLE 4 (JLJ684), A NON-NUCLEOSIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66; COMPND 5 SYNONYM: EXORIBONUCLEASE H, P66 RT; COMPND 6 EC: 2.7.7.49, 2.7.7.7, 3.1.26.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: P51 RT; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: P51; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 3 SUBTYPE B (ISOLATE BH10); SOURCE 4 ORGANISM_COMMON: HIV-1; SOURCE 5 ORGANISM_TAXID: 11678; SOURCE 6 STRAIN: ISOLATE BH10; SOURCE 7 GENE: GAG-POL; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PCDF-2; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 15 SUBTYPE B (ISOLATE BH10); SOURCE 16 ORGANISM_COMMON: HIV-1; SOURCE 17 ORGANISM_TAXID: 11678; SOURCE 18 STRAIN: ISOLATE BH10; SOURCE 19 GENE: GAG-POL; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 22 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 23 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 24 EXPRESSION_SYSTEM_PLASMID: PCDF-2 KEYWDS POLYMERASE, REVERSE TRANSCRIPTASE, HIV, NON-NUCLEOSIDE INHIBITOR, KEYWDS 2 TRANSFERASE, HYDROLASE-INHIBITOR COMPLEX, TRANSFERASE-HYDROLASE- KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.H.CHAN,K.S.ANDERSON REVDAT 5 04-OCT-23 5VQV 1 REMARK REVDAT 4 11-DEC-19 5VQV 1 REMARK REVDAT 3 20-SEP-17 5VQV 1 JRNL REVDAT 2 06-SEP-17 5VQV 1 JRNL REVDAT 1 23-AUG-17 5VQV 0 JRNL AUTH A.H.CHAN,W.G.LEE,K.A.SPASOV,J.A.CISNEROS,S.N.KUDALKAR, JRNL AUTH 2 Z.O.PETROVA,A.B.BUCKINGHAM,K.S.ANDERSON,W.L.JORGENSEN JRNL TITL COVALENT INHIBITORS FOR ERADICATION OF DRUG-RESISTANT HIV-1 JRNL TITL 2 REVERSE TRANSCRIPTASE: FROM DESIGN TO PROTEIN JRNL TITL 3 CRYSTALLOGRAPHY. JRNL REF PROC. NATL. ACAD. SCI. V. 114 9725 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28827354 JRNL DOI 10.1073/PNAS.1711463114 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 40173 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2369 - 6.2124 0.99 2804 147 0.1746 0.1996 REMARK 3 2 6.2124 - 4.9332 0.99 2756 144 0.2023 0.2339 REMARK 3 3 4.9332 - 4.3103 0.99 2738 144 0.1910 0.2287 REMARK 3 4 4.3103 - 3.9165 0.99 2706 141 0.2020 0.1992 REMARK 3 5 3.9165 - 3.6359 1.00 2746 144 0.2183 0.2501 REMARK 3 6 3.6359 - 3.4216 1.00 2705 142 0.2419 0.2964 REMARK 3 7 3.4216 - 3.2503 1.00 2734 143 0.2703 0.2966 REMARK 3 8 3.2503 - 3.1089 1.00 2709 142 0.2679 0.3117 REMARK 3 9 3.1089 - 2.9892 1.00 2728 143 0.2717 0.2973 REMARK 3 10 2.9892 - 2.8861 1.00 2709 142 0.2745 0.3742 REMARK 3 11 2.8861 - 2.7959 1.00 2689 141 0.2825 0.3195 REMARK 3 12 2.7959 - 2.7160 1.00 2721 143 0.2927 0.3632 REMARK 3 13 2.7160 - 2.6445 1.00 2699 141 0.3009 0.3403 REMARK 3 14 2.6445 - 2.5800 1.00 2729 143 0.3026 0.3569 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.740 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 7981 REMARK 3 ANGLE : 0.487 10860 REMARK 3 CHIRALITY : 0.042 1178 REMARK 3 PLANARITY : 0.003 1366 REMARK 3 DIHEDRAL : 10.655 4781 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VQV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227647. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS NOV 1, 2016 REMARK 200 DATA SCALING SOFTWARE : XSCALE NOV 1, 2016 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40186 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 43.231 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.707 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.62700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.120 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX 1.10.1_2155 REMARK 200 STARTING MODEL: 5VQQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM IMIDAZOLE PH 6.5, 16% PEG 8,000, REMARK 280 100 MM AMMONIUM SULFATE, 15 MM MAGNESIUM SULFATE, AND 5 MM REMARK 280 SPERMINE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 81.25500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.77000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 81.25500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.77000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 64 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 213 REMARK 465 LEU B 214 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 22 CG CD CE NZ REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LYS B 11 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 184 -129.23 54.14 REMARK 500 ASP A 185 34.80 -98.55 REMARK 500 ILE A 270 -27.74 -141.72 REMARK 500 THR A 286 -63.32 -91.81 REMARK 500 PHE A 346 -1.08 71.79 REMARK 500 PRO A 412 -179.27 -69.77 REMARK 500 HIS A 539 17.34 57.38 REMARK 500 PRO B 97 99.41 -68.58 REMARK 500 MET B 184 -128.05 55.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9J1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TER RELATED DB: PDB REMARK 900 RELATED ID: 5VQX RELATED DB: PDB REMARK 900 RELATED ID: 5VQY RELATED DB: PDB REMARK 900 RELATED ID: 5VQZ RELATED DB: PDB REMARK 900 RELATED ID: 5VQQ RELATED DB: PDB REMARK 900 RELATED ID: 5VQR RELATED DB: PDB REMARK 900 RELATED ID: 5VQS RELATED DB: PDB REMARK 900 RELATED ID: 5VQT RELATED DB: PDB REMARK 900 RELATED ID: 5VQU RELATED DB: PDB REMARK 900 RELATED ID: 5VQW RELATED DB: PDB DBREF 5VQV A 1 555 UNP P03366 POL_HV1B1 600 1154 DBREF 5VQV B 1 428 UNP P03366 POL_HV1B1 600 1027 SEQADV 5VQV MET A -1 UNP P03366 EXPRESSION TAG SEQADV 5VQV VAL A 0 UNP P03366 EXPRESSION TAG SEQADV 5VQV ALA A 172 UNP P03366 LYS 771 ENGINEERED MUTATION SEQADV 5VQV ALA A 173 UNP P03366 LYS 772 ENGINEERED MUTATION SEQADV 5VQV CYS A 181 UNP P03366 TYR 780 ENGINEERED MUTATION SEQADV 5VQV SER A 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQADV 5VQV SER B 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQRES 1 A 557 MET VAL PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS SEQRES 2 A 557 LEU LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP SEQRES 3 A 557 PRO LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE SEQRES 4 A 557 CYS THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE SEQRES 5 A 557 GLY PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE SEQRES 6 A 557 LYS LYS LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP SEQRES 7 A 557 PHE ARG GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU SEQRES 8 A 557 VAL GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS SEQRES 9 A 557 LYS LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR SEQRES 10 A 557 PHE SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR SEQRES 11 A 557 ALA PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY SEQRES 12 A 557 ILE ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS SEQRES 13 A 557 GLY SER PRO ALA ILE PHE GLN SER SER MET THR LYS ILE SEQRES 14 A 557 LEU GLU PRO PHE ALA ALA GLN ASN PRO ASP ILE VAL ILE SEQRES 15 A 557 CYS GLN TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU SEQRES 16 A 557 GLU ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG SEQRES 17 A 557 GLN HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS SEQRES 18 A 557 LYS HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR SEQRES 19 A 557 GLU LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL SEQRES 20 A 557 LEU PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN SEQRES 21 A 557 LYS LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR SEQRES 22 A 557 PRO GLY ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG SEQRES 23 A 557 GLY THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU SEQRES 24 A 557 GLU ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU SEQRES 25 A 557 LYS GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS SEQRES 26 A 557 ASP LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN SEQRES 27 A 557 TRP THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU SEQRES 28 A 557 LYS THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR SEQRES 29 A 557 ASN ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE SEQRES 30 A 557 THR THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS SEQRES 31 A 557 PHE LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP SEQRES 32 A 557 TRP THR GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP SEQRES 33 A 557 GLU PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR SEQRES 34 A 557 GLN LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE SEQRES 35 A 557 TYR VAL ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY SEQRES 36 A 557 LYS ALA GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL SEQRES 37 A 557 VAL PRO LEU THR ASN THR THR ASN GLN LYS THR GLU LEU SEQRES 38 A 557 GLN ALA ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU SEQRES 39 A 557 VAL ASN ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE SEQRES 40 A 557 ILE GLN ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL SEQRES 41 A 557 ASN GLN ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL SEQRES 42 A 557 TYR LEU ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY SEQRES 43 A 557 ASN GLU GLN VAL ASP LYS LEU VAL SER ALA GLY SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET 9J1 A 601 37 HET SO4 A 602 5 HETNAM 9J1 N-(6-CYANO-3-{2-[2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- HETNAM 2 9J1 1(2H)-YL)ETHOXY]PHENOXY}-4-METHYLNAPHTHALEN-1-YL)-N- HETNAM 3 9J1 METHYLPROPANAMIDE HETNAM SO4 SULFATE ION FORMUL 3 9J1 C28 H26 N4 O5 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *94(H2 O) HELIX 1 AA1 THR A 27 GLY A 45 1 19 HELIX 2 AA2 PHE A 77 THR A 84 1 8 HELIX 3 AA3 HIS A 96 LEU A 100 5 5 HELIX 4 AA4 GLY A 112 VAL A 118 5 7 HELIX 5 AA5 ASP A 121 LYS A 126 1 6 HELIX 6 AA6 TYR A 127 ALA A 129 5 3 HELIX 7 AA7 SER A 134 GLU A 138 5 5 HELIX 8 AA8 GLY A 155 GLN A 174 1 20 HELIX 9 AA9 GLU A 194 ARG A 211 1 18 HELIX 10 AB1 THR A 253 SER A 268 1 16 HELIX 11 AB2 VAL A 276 LEU A 282 1 7 HELIX 12 AB3 THR A 296 LEU A 310 1 15 HELIX 13 AB4 ASN A 363 GLY A 384 1 22 HELIX 14 AB5 GLN A 394 TYR A 405 1 12 HELIX 15 AB6 THR A 473 ASP A 488 1 16 HELIX 16 AB7 SER A 499 GLN A 507 1 9 HELIX 17 AB8 SER A 515 LYS A 528 1 14 HELIX 18 AB9 THR B 27 GLU B 44 1 18 HELIX 19 AC1 PHE B 77 THR B 84 1 8 HELIX 20 AC2 VAL B 111 PHE B 116 1 6 HELIX 21 AC3 PHE B 124 ALA B 129 5 6 HELIX 22 AC4 SER B 134 GLU B 138 5 5 HELIX 23 AC5 LYS B 154 PHE B 160 1 7 HELIX 24 AC6 PHE B 160 ASN B 175 1 16 HELIX 25 AC7 GLU B 194 ARG B 211 1 18 HELIX 26 AC8 HIS B 235 TRP B 239 5 5 HELIX 27 AC9 VAL B 254 SER B 268 1 15 HELIX 28 AD1 VAL B 276 LEU B 283 1 8 HELIX 29 AD2 THR B 296 GLU B 312 1 17 HELIX 30 AD3 ASN B 363 GLY B 384 1 22 HELIX 31 AD4 GLN B 394 TRP B 402 1 9 HELIX 32 AD5 THR B 403 TYR B 405 5 3 HELIX 33 AD6 PRO B 421 GLN B 428 5 8 SHEET 1 AA1 3 ILE A 47 LYS A 49 0 SHEET 2 AA1 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 AA1 3 PHE A 130 ILE A 132 -1 N PHE A 130 O TYR A 144 SHEET 1 AA2 2 VAL A 60 ALA A 62 0 SHEET 2 AA2 2 LYS A 73 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 AA3 3 SER A 105 ASP A 110 0 SHEET 2 AA3 3 ASP A 186 SER A 191 -1 O VAL A 189 N THR A 107 SHEET 3 AA3 3 ILE A 178 TYR A 183 -1 N TYR A 183 O ASP A 186 SHEET 1 AA4 3 PHE A 227 TRP A 229 0 SHEET 2 AA4 3 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 AA4 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AA5 5 LYS A 347 ALA A 355 0 SHEET 2 AA5 5 GLN A 336 GLU A 344 -1 N ILE A 341 O LYS A 350 SHEET 3 AA5 5 ILE A 326 GLY A 333 -1 N GLN A 330 O THR A 338 SHEET 4 AA5 5 LYS A 388 LEU A 391 1 O LYS A 390 N ALA A 327 SHEET 5 AA5 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AA6 2 HIS A 361 THR A 362 0 SHEET 2 AA6 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 AA7 5 GLN A 464 LEU A 469 0 SHEET 2 AA7 5 GLY A 453 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 AA7 5 GLU A 438 ALA A 446 -1 N TYR A 441 O VAL A 458 SHEET 4 AA7 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 AA7 5 LYS A 530 TRP A 535 1 O ALA A 534 N ILE A 495 SHEET 1 AA8 3 ILE B 47 LYS B 49 0 SHEET 2 AA8 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 AA8 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 AA9 2 VAL B 60 ILE B 63 0 SHEET 2 AA9 2 ARG B 72 VAL B 75 -1 O LEU B 74 N PHE B 61 SHEET 1 AB1 4 VAL B 179 TYR B 183 0 SHEET 2 AB1 4 ASP B 186 SER B 191 -1 O GLY B 190 N VAL B 179 SHEET 3 AB1 4 SER B 105 ASP B 110 -1 N SER B 105 O SER B 191 SHEET 4 AB1 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 AB2 2 TRP B 252 THR B 253 0 SHEET 2 AB2 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 AB3 5 LYS B 347 TYR B 354 0 SHEET 2 AB3 5 GLN B 336 GLU B 344 -1 N ILE B 341 O LYS B 350 SHEET 3 AB3 5 ILE B 326 GLY B 333 -1 N ILE B 326 O TYR B 342 SHEET 4 AB3 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 AB3 5 GLU B 413 PHE B 416 1 O GLU B 415 N LEU B 391 LINK SG CYS A 181 C28 9J1 A 601 1555 1555 1.82 CISPEP 1 PRO A 225 PRO A 226 0 -5.42 CISPEP 2 PRO A 420 PRO A 421 0 -0.98 SITE 1 AC1 12 LYS A 101 LYS A 102 LYS A 103 CYS A 181 SITE 2 AC1 12 GLN A 182 TYR A 188 PHE A 227 TRP A 229 SITE 3 AC1 12 LEU A 234 HIS A 235 PRO A 236 TYR A 318 SITE 1 AC2 4 LYS A 331 GLY A 333 GLN A 334 LYS A 512 CRYST1 162.510 73.540 109.230 90.00 99.42 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006153 0.000000 0.001021 0.00000 SCALE2 0.000000 0.013598 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009280 0.00000